Hua Han Bio-Pharmaceutical Holdings Ltd. (00587.HK) said in a regulatory filing on Tuesday its net profit for the fiscal year to June dropped 66.1 percent to HK$223 million (US$28.75 million) from a year earlier. It attributed the earnings decline to a sharp rise in sales and distribution costs. The company proposed a final dividend of 2.3 HK cents and a special dividend of 4 HK cents per share. The board also approved a bonus issue of shares at one new ordinary share for every five existing ordinary shares, the filing said.
– Contact HKEJ [email protected]